Newsletters -April 2000

Newsletters -April 2000

The National Academy of Sciences (NAS) released a report on April 11th reviewing the emerging science of antioxidants and their potential for disease protection. As summarized by the Council for Responsible Nutrition, although the report did not conclude that scientific evidence is sufficiently consistent to permit recommended intakes based on disease prevention, it did recognize the wide range of safe intakes for antioxidant vitamins and issued higher Recommended Dietary Allowances (RDAs) for vitamins C and E. The new RDAs for antioxidant nutrients are: vitamin C (75 milligrams (mg) for women and 90 mg for men), vitamin E (15 mg), and selenium (55 micrograms (mcg)).

The report stated that there is "reason to expect that the antioxidant vitamins (C and E) should decrease the risk of cardiovascular disease." The report concluded that vitamin E does inhibit LDL oxidation (a causative agent for cardiovascular disease) and could also affect the health of arteries in other ways. The report also noted that it is reasonable to expect that vitamin C would reduce oxidative damage to the eye, thus lessening the risk of cataracts and other conditions. The NAS report also established tolerable upper intake levels (ULs) for vitamin C (2,000 mg), vitamin E (1,000 mg) and selenium (400 mcg). ULs for adults are set to protect the most sensitive individuals of the general population.

    VISIT US

  • Sabinsa Europe GmbH
    Monzastrasse 4
    63225 Langen
    Germany

  • +49 6103 270 11 11
  • +49 6103 270 11 27
  • info@sabinsa.eu

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.